Companies / Czech Republic
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Another Generics Acquisition For Big Pharma
June 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
In what is the second deal of its kind in a week, another multinational innovative pharmaceutical company is looking to expand in the generics arena. Following the US$4.6bn takeover deal between Daiichi Sankyo and Ranbaxy, Sanofi-Aventis announced on 18 June 2008 that it had launched a CZK40.04bn (US$2.60bn) bid to acquire Czech-based